Cutaneous hypersensitivity and desensitization to mechlorethamine in patients with mycosis fungoides lymphoma.
D003520:Cyclophosphamide / Q000494:pharmacology; D003877:Dermatitis, Contact; D003888:Desensitization, Immunologic; D004304:Dosage Forms; D004342:Drug Hypersensitivity; D006801:Humans; D006968:Hypersensitivity, Delayed; D007275:Injections, Intravenous; D008223:Lymphoma / Q000188:drug therapy; D008466:Mechlorethamine / Q000008:administration & dosage / Q000627:therapeutic use*; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000276:immunology; D009578:Nitrobenzenes / Q000494:pharmacology; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D012877:Skin Manifestations / Q000188:drug therapy*; D012882:Skin Tests
D004304:Dosage Forms; D009578:Nitrobenzenes; D009588:Nitrogen Mustard Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide